Skip to main content

Kyber Data Science Launches Next-Gen Health Care Data Platform for Institutional Investors

Written by Customer Service on . Posted in Public Companies.

NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) — Institutional investors can now readily access the most diverse and granular source of real-world health care data available, enabling faster and more profitable decisions. Kyber Data Science (“Kyber”), a subsidiary of Cowen Inc. (NASDAQ: COWN) (“Cowen”), today unveiled a next-generation user experience to disentangle and simplify complex health care data and provide visibility into the specific market influences that drive performance.

Kyber Data Science is the first in its industry to enrich real-world health care data exclusively for the investment community. Its new dashboard allows investors to track utilization of health care treatments, even in pharmaceutical and biopharmaceuticals markets that have long been “information voids,” such as injectables and infusions, diagnostics, procedures and medical devices.

“For some time, Kyber has offered investors a unique dataset covering 300 million deidentified U.S. patients, with over seven years of longitudinal history,” said Jeff Forringer, CEO of Kyber Data Science. “Our new user interface makes this data even easier to analyze and generate actionable insights relevant to investment decisions.”

What Makes Kyber’s Data Unique?

Built by a team of health care data science experts within the Cowen ecosystem, Kyber Data Science’s offerings represent the next-generation evolution of investors’ existing health care data subscriptions.

Kyber’s new user interface tracks the most important signals to watch for across most health care procedures, prescriptions and services. Additionally, the Kyber team provides unique insights into areas where most investors today have limited or no visibility, such as:

  1. Prescription and medically-administered treatment utilization, to help forecast revenue and market share trends
  2. True new-to-brand patients, to better understand new patient expansion rates
  3. Patient compliance and persistence, to quantify patient loyalty and market value
  4. Payer-related insights, to track patient access and payer coverage for drugs of interest

To schedule a demonstration, contact Kyber@Cowen.com.

About Kyber Data Science
Kyber Data Science, a Cowen company, is an advanced health care data company that offers analytical tools to help health care investors make better portfolio decisions. It delivers enriched, real-world healthcare insights to help investors understand U.S. market forces, as they’re unfolding, across complex points of care and payment. Learn more at Kyber.ai.

About Cowen Inc.

Cowen Inc. (“Cowen” or the “Company”) is a diversified financial services firm offering investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services and actively managed alternative investment products. Cowen focuses on delivering value-added capabilities to our clients in order to help them outperform. Founded in 1918, the Company is headquartered in New York and has offices worldwide. Learn more at Cowen.com.

Media Contacts:

Gagnier Communications
Dan Gagnier / Jeffrey Mathews
646-569-5897
dg@gagnierfc.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.